Advances in Parkinson’s Disease Drugs
Parkinson’s disease (PD) is the second most common neurodegenerative age-related disorder worldwide after Alzheimer’s disease [...]
Guardado en:
Autores principales: | Antonio Di Stefano, Lisa Marinelli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c8ad30ef0fa4425080e6c0165b7ab81f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Anticancer Platinum Drugs Update
por: Giuliano Ciarimboli
Publicado: (2021) -
Recent Advances in Translational Adipose-Derived Stem Cell Biology
por: Darius Widera
Publicado: (2021) -
Cutting Edge Research for Exploration of Biomolecules for Gemcitabine-Based Chemo-Resistant Advanced Bile Duct Cancer: From Basic Study to Clinical Trial
por: Chiao-En Wu, et al.
Publicado: (2021) -
Treating Cancers Using Nature’s Medicine: Significance and Challenges
por: Samson Mathews Samuel, et al.
Publicado: (2021) -
Reimagining the Power of Nucleic Acids as Therapeutic and Diagnostic Agents
por: Anthony Berdis
Publicado: (2021)